Related Experiment Video
Updated: Sep 18, 2025

Intraoperative Assessment of Resection Margins in Oral Cavity Cancer: This is the Way
Published on: May 10, 2021
Evaluating Treatment Plan Modifications from Surgeons' Initial Recommendations to Multidisciplinary Tumor Board
Sajida Qureshi1, Waqas Ahmad Abbasi1, Hira Abdul Jalil1
1Dow Medical College, Dow University of Health Sciences, Karachi 74200, Pakistan.
Multidisciplinary tumor boards (MTBs) strongly agree with surgeon recommendations for cancer care. MTBs refine treatment plans, ensuring consistent, evidence-based patient management.
Area of Science:
- Oncology
- Healthcare Management
- Clinical Decision-Making
Background:
- Multidisciplinary tumor boards (MTBs) are crucial for collaborative cancer care.
- Limited data exists on surgeon recommendation concordance with MTB outcomes, especially in resource-limited settings.
Purpose of the Study:
- To evaluate agreement between initial surgeon recommendations and MTB-finalized treatment plans.
- To assess changes in treatment intent (curative vs. palliative) and MTB decision implementation.
Main Methods:
- Retrospective analysis of 216 patients discussed in MTBs (Jan 2021-Dec 2023).
- Utilized kappa statistics and concordance analysis to assess agreement.
- Focused on treatment intent shifts and implementation rates.
Main Results:
- Strong concordance observed between surgeon and MTB decisions (Cohen's kappa = 0.89, p < 0.001).
- MTB recommendations modified or replaced surgeon plans in 63.4% of cases.
- MTB decisions were implemented in 100% of cases; shifts in treatment intent were infrequent.
Conclusions:
- MTBs play a vital role in collaborative cancer care decision-making.
- MTBs ensure consistent, individualized, and evidence-based treatment plans.
- High concordance and implementation rates highlight MTB value in optimizing patient care.
More Related Videos
08:54Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
Published on: May 8, 2018
12:45Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
Published on: February 12, 2022
Related Concept Videos
Cancer Survival Analysis
Treatment Resistant Cancers